Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains

Treanor, J. J., Talbot, H. K., Ohmit, S. E., Coleman, L. A., Thompson, M. G., Cheng, P.-Y., Petrie, J. G., Lofthus, G. +9 more·2012·Clinical Infectious Diseases

Cited by (258)

Items 101–200 of 258

  1. Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016–2017 and 2017–2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
    Emily Toth Martin, Caroline K. Cheng, Joshua G. Petrie, Elif Alyanak, Manjusha Gaglani, Donald B. Middleton, Shekhar A Ghamande, Fernanda P. Silveira, Kempapura Murthy, Richard Kent Zimmerman et al. · 2020 · The Journal of Infectious Diseases
  2. Nanoparticles and Antiviral Vaccines
    Sen Liu, Meilin Hu, Xiaoqing Liu, Xingyu Liu, Tao Chen, Yiqiang Zhu, Taizhen Liang, Shiqi Xiao, Peiwen Li, Xiancai Ma · 2023 · Vaccines
  3. Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010–13, United States
    Benjamin John Cowling, Shuo Feng, Lyn Finelli, Andrea Steffens, Ashley L. Fowlkes · 2015 · Vaccine
  4. Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections
    Maya K. Monroe, Han Wang, Caleb F. Anderson, Hongpeng Jia, Charles W. Flexner, Honggang Cui · 2022 · Journal of Controlled Release
  5. Viral infections in outpatients with medically attended acute respiratory illness during the 2012–2013 influenza season
    Richard Kent Zimmerman, Charles R. Rinaldo, Mary Patricia Nowalk, Goundappa K. Balasubramani, Krissy Moehling Geffel, Arlene Bullotta, Heather F. Eng, Jonathan M. Raviotta, Theresa M. Sax, Stephen R. Wisniewski · 2015 · BMC Infectious Diseases
  6. Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease
    Andrea S. Gershon, Hannah Chung, Joan Porter, Michael A. Campitelli, Sarah A. Buchan, Kevin L. Schwartz, Natasha Sarah Crowcroft, Aaron J. Campigotto, Jonathan B. Gubbay, Timothy Karnauchow et al. · 2019 · The Journal of Infectious Diseases
  7. Vaccination against Paediatric Respiratory Pathogens
    Sonia Bianchini, Alberto Argentiero, Barbara Camilloni, Ettore Silvestri, Anna Alunno, Susanna Esposito · 2019 · Vaccines
  8. Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012–2013 case–control evaluation of influenza vaccine effectiveness
    Chuanxi Fu, Jianxiong Xu, Jinyan Lin, Ming Wang, Kuibiao Li, Jing Ge, Mark G. Thompson · 2015 · Vaccine
  9. The National Influenza Surveillance System of Korea
    Won Suk Choi · 2019 · Infection and Chemotherapy
  10. Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
    Amanda C. Perofsky, John Huddleston, C. Hansen, John Barnes, Thomas Rowe, Xiyan Xu, Rebecca J Garten Kondor, David E. Wentworth, Nicola S. Lewis, Lynne Whittaker et al. · 2024 · eLife
  11. Effectiveness of Monovalent 2009 Pandemic Influenza A Virus Subtype H1N1 and 2010–2011 Trivalent Inactivated Influenza Vaccines in Wisconsin During the 2010–2011 Influenza Season
    Allen Bateman, Burney A. Kieke, Stephanie A. Irving, Jennifer K. Meece, David K. Shay, Edward A. Belongia · 2013 · The Journal of Infectious Diseases
  12. Efficacy of trivalent influenza vaccine against laboratory-confirmed influenza among young children in a randomized trial in Bangladesh
    Melissa A R Rolfes, Doli Rani Goswami, Amina Tahia Sharmeen, Sultana Yeasmin, Nasrin Parvin, Kamrun Nahar, Mustafizur Rahman, M. Barends, Dilruba Ahmed, Mohammed Ziaur Rahman et al. · 2017 · Vaccine
  13. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults
    Joon Young Song, Hee Jin Cheong, Hakjun Hyun, Yu Bin Seo, Jacob Lee, Seong‐Heon Wie, Min Joo Choi, Won Suk Choi, Ji Yun Noh, Jae-Won Yun et al. · 2016 · Vaccine
  14. Influenza vaccination coverage and effectiveness in young children in Thailand, 2011–2013
    Wanitchaya Kittikraisak, Piyarat Suntarattiwong, Jens Levy, Stefan Fernandez, Fatimah S. Dawood, Sonja J. Olsen, Tawee Chotpitayasunondh · 2015 · Influenza and Other Respiratory Viruses
  15. Decline in Seasonal Influenza Vaccine Effectiveness With Vaccination Program Maturation: A Systematic Review and Meta-analysis
    George N. Okoli, Florentin Racovitan, Tiba Abdulwahid, Syed K Hyder, Louise Lansbury, Christiaan H. Righolt, Salaheddin M. Mahmud, Jonathan S. Nguyen‐Van‐Tam · 2021 · Open Forum Infectious Diseases
  16. Inactivated Influenza Vaccines
    Joseph Bresee, Alicia M. Fry, Suryaprakash R. Sambhara, Nancy J. Cox · 2017 · Elsevier eBooks
  17. Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study – exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine
    Colin R Simpson, Nazir Lone, Kimberley Kavanagh, LD Ritchie, Christopher Robertson, Aziz Sheikh, Jim McMenamin · 2013 · Health Services and Delivery Research
  18. A method of processing nasopharyngeal swabs to enable multiple testing
    Santiago M. C. Lopez, Judith M. Martin, Monika Johnson, Marcia Kurs‐Lasky, William T. Horne, C. W. Marshall, Vaughn S. Cooper, John V. Williams, Nader Shaikh · 2019 · Pediatric Research
  19. Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study
    Arnold S. Monto, Ryan E. Malosh, Richard Evans, Adam S. Lauring, Aubree L. Gordon, Mark G. Thompson, Alicia M. Fry, Brendan L. Flannery, Suzanne E. Ohmit, Joshua G. Petrie et al. · 2019 · International Journal of Epidemiology
  20. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza‐associated acute respiratory infection among Thai adults aged ≥50 years
    Fatimah S. Dawood, Prabda Praphasiri, Peera Areerat, Asadang Ruayajin, Malinee Chittaganpitch, Charung Muangchana, Henry C. Baggett, Sonja J. Olsen · 2014 · Influenza and Other Respiratory Viruses
  21. When Externalities Collide: Influenza and Pollution
    Joshua Graff Zivin, Matthew Neidell, Nicholas Sanders, Gregor Singer · 2023 · American Economic Journal Applied Economics
  22. Prevalence and Predictors of Seasonal Influenza Vaccine Uptake in Saudi Arabia Post COVID-19: A Web-Based Online Cross-Sectional Study
    Saeed Mastour Alshahrani, Yousef I. Zahrani · 2023 · Vaccines
  23. Variable definitions of the influenza season and their impact on vaccine effectiveness estimates
    Sheena G. Sullivan, Ee Laine Tay, Heath A. Kelly · 2013 · Vaccine
  24. Annual Burden of Occupationally‐Acquired Influenza Infections in Hospitals and Emergency Departments in the United States
    Rachael M. Jones, Yulin Xia · 2017 · Risk Analysis
  25. Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells
    Michael Estrin, Islam T. M. Hussein, Wendy Blay Puryear, Anne C. Kuan, Stephen C. Artim, Jonathan A. Runstadler · 2018 · PLoS ONE
  26. Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults
    Desmond Loong, Ba’ Pham, Mohammadreza Amiri, Hailey Saunders, Sujata Mishra, Amruta Radhakrishnan, Myanca Rodrigues, Man Wah Yeung, Matthew Paul Muller, Sharon Elizabeth Straus et al. · 2022 · Value in Health
  27. Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium
    Adriaan Blommaert, Joke Bilcke, Yannick Vandendijck, Germaine Hanquet, Niel Hens, Philippe Beutels · 2014 · Vaccine
  28. Influenza Vaccine Prevents Medically Attended Influenza-Associated Acute Respiratory Illness in Adults Aged ≥50 Years
    Qingxia Chen, Marie R. Griffin, Hui Nian, Yuwei Zhu, John V. Williams, Kathryn M. Edwards, H. Keipp Talbot · 2014 · The Journal of Infectious Diseases
  29. Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
    Sreeja Biswas Roy, Clare M. Williams, Danushka K. Wijesundara, Yoichi Furuya · 2020 · Vaccines
  30. Seasonal influenza vaccine effectiveness among children, 2010–2012
    Chuanxi Fu, Qing He, Zhaotian Li, Jianxiong Xu, Yongqian Li, Jianyun Lu, Kuibiao Li, Qiongying Yang, Zhiqiang Dong, Xiangyi Liu et al. · 2013 · Influenza and Other Respiratory Viruses
  31. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain
    Alin Gherasim, Iván Martínez‐Baz, Jesús Castilla, Francisco Pozo, Amparo Larrauri, the cycEVA working group · 2017 · PLoS ONE
  32. Antiviral Treatment among Older Adults Hospitalized with Influenza, 2006-2012
    Mary Lou Lindegren, Marie R. Griffin, John V. Williams, Kathryn M. Edwards, Yuwei Zhu, Edward F. Mitchel, Alicia M. Fry, William Schaffner, H. Keipp Talbot · 2015 · PLoS ONE
  33. Improving Influenza Vaccine Effectiveness: Ways to Begin Solving the Problem
    Arnold S. Monto, Joshua G. Petrie · 2019 · Clinical Infectious Diseases
  34. Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis
    Anke L. Stuurman, Joshua Enxing, Aura V. Gutiérrez, Christen M. Gray, Ingrid T. Sepúlveda-Pachón, Egbe Ubamadu, Allyn R Bandell, Sylvia Taylor, Georges El Azzi, Wilhelmine Hadler Meeraus · 2025 · Expert Review of Vaccines
  35. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain
    Gregory A. Poland, Douglas Fleming, John J. Treanor, Eugene Maraskovsky, Thomas C Luke, Emma M. A. Ball, Caroline M. Poland · 2013 · Vaccine
  36. Incidence and viral aetiologies of acute respiratory illnesses (ARIs) in the United States: a population-based study
    Peter G. Szilagyi, Aaron K. Blumkin, John J. Treanor, Sarah Gallivan, Christina S. Albertin, Gerry Lofthus, Kenneth C. Schnabel, James G. Donahue, Mark G. Thompson, David K. Shay · 2016 · Epidemiology and Infection
  37. Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment
    Annette K. Regan, James Fielding, Monique B-N Chilver, Kylie S Carville, Cara A Minney-Smith, Kristina A Grant, Chloe Thomson, Trish Hahesy, Yi‐Mo Deng, Nigel Stocks et al. · 2019 · Vaccine
  38. Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection
    Yo Han Jang, Baik Lin Seong · 2020 · Expert Opinion on Drug Discovery
  39. Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6–59 Months Old During Four Seasons
    Melissa D. Simpson, Burney A. Kieke, Maria E. Sundaram, David L. McClure, Jennifer K. Meece, Frangiscos Sifakis, Robert A. Gasser, Edward A. Belongia · 2016 · Open Forum Infectious Diseases
  40. Relative timing of influenza disease by age group
    Timothy R. Peters, Beverly M. Snively, Cynthia K. Suerken, Elizabeth S. Blakeney, Lauren Vannoy, Katherine A. Poehling · 2014 · Vaccine
  41. Elementary School-Based Influenza Vaccination: Evaluating Impact on Respiratory Illness Absenteeism and Laboratory-Confirmed Influenza
    Sonia A. Kjos, Stephanie A. Irving, Jennifer K. Meece, Edward A. Belongia · 2013 · PLoS ONE
  42. Predictors of Influenza Diagnosis Among Patients With Laboratory-Confirmed Influenza
    Marc R. Miller, Timothy R. Peters, Cynthia K. Suerken, Beverly Snively, Katherine A. Poehling · 2015 · The Journal of Infectious Diseases
  43. Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6–59 months, October 2011–September 2012: A matched test-negative case–control study in Suzhou, China
    Yin Wang, Tao Zhang, Liling Chen, Carolyn M. Greene, Yunfang Ding, Yuejia Cheng, Chao Yuh Yang, Shanshan Zeng, Jun Hua, Suizan Zhou et al. · 2016 · Vaccine
  44. Influenza Vaccine Effectiveness in the Tropics: Moderate Protection in a Case Test-Negative Analysis of a Hospital-Based Surveillance Population in Bangkok between August 2009 and January 2013
    Jens Levy, Sriluck Simasathien, Veerachai Watanaveeradej, Piraya Bhoomiboonchoo, Stefan Fernandez, Richard G. Jarman, Chonticha Klungthong, Robert V. Gibbons, Phirangkool Kerdpanich, Danaband Piboonbanakit et al. · 2015 · PLoS ONE
  45. Declining Influenza Vaccination Coverage among Nurses, Hong Kong, 2006–2012
    Shui Shan Lee, Ngai Sze Wong, Sing Lee · 2013 · Emerging infectious diseases
  46. Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach
    C.R. Lane, Kylie S Carville, Nevil Pierse, H Kelly · 2016 · Vaccine
  47. Immunogenicity of Enhanced Influenza Vaccines Against Mismatched Influenza Strains in Older Adults: A Review of Randomized Controlled Trials
    John E. Youhanna, Vy Tran, Randall N. Hyer, Alexander Domnich · 2024 · Influenza and Other Respiratory Viruses
  48. Influenza and pneumococcal vaccination in older adults living in nursing home: a survival analysis on the shelter study
    Andrea Poscia, Agnese Collamati, Angelo Carfì, Eva Topinková, Tomáš Richter, Michael Dieter Denkinger, Roberta Pastorino, Francesco Landi, Walter Ricciardi, Roberto Bernabei et al. · 2017 · European Journal of Public Health
  49. Real-time real-world analysis of seasonal influenza vaccine effectiveness: method development and assessment of a population-based cohort in Stockholm County, Sweden, seasons 2011/12 to 2014/15
    Amy Levál, Maria Pia Hergens, Karin Persson, Åke Örtqvist · 2016 · Eurosurveillance
  50. Perspectives from the Society for Pediatric Research: Decreased Effectiveness of the Live Attenuated Influenza Vaccine
    Michelle Ann Gill, Elizabeth P. Schlaudecker · 2017 · Pediatric Research
  51. Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
    Amanda C. Perofsky, John Huddleston, C. Hansen, John Barnes, Thomas Rowe, Xiyan Xu, Rebecca J Garten Kondor, David E. Wentworth, Nicola S. Lewis, Lynne Whittaker et al. · 2024 · eLife
  52. Simulation Study of the Effect of Influenza and Influenza Vaccination on Risk of Acquiring Guillain-Barré Syndrome
    Steven Hawken, Jeffrey C. Kwong, Shelley L. Deeks, Natasha Sarah Crowcroft, Allison McGeer, Robin Ducharme, Michael A. Campitelli, Doug Coyle, Kumanan R Wilson · 2015 · Emerging infectious diseases
  53. Implementation of a Mandatory Influenza Vaccine Policy: A 10-Year Experience
    Eimear M. Kitt, Sharon Burt, Susan McLaughlin Price, Lauren N. Satchell, Paul A. Offit, Julia Shaklee Sammons, Susan E Coffin · 2020 · Clinical Infectious Diseases
  54. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany
    Cornelius Remschmidt, Thorsten Rieck, Birte Bödeker, Ole Wichmann · 2015 · BMC Infectious Diseases
  55. Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high‐income countries: a meta‐analysis
    Sarah A. Buchan, Travis J. Salway, Laura C. Rosella, Natasha Sarah Crowcroft, Dat Thien Tran, Jeffrey C. Kwong · 2016 · Influenza and Other Respiratory Viruses
  56. Optimal individual strategies for influenza vaccines with imperfect efficacy and durability of protection
    Francesco Salvarani, Gabriel Turinici · 2018 · Mathematical Biosciences & Engineering
  57. Effectiveness of seasonal influenza vaccinations against laboratory‐confirmed influenza‐associated infections among S ingapore military personnel in 2010–2013
    Hin Peow Ho, Xiahong Zhao, Junxiong Pang, Mark I-Cheng Chen, Vernon J. M. Lee, Li Wei Ang, Raymond V. Tzer Pin Lin, Christine Gao, Li Yang Hsu, Alex Richard Cook · 2014 · Influenza and Other Respiratory Viruses
  58. Seasonal influenza vaccine effectiveness in pre- and full-term children aged 6–23 months over multiple seasons
    Shixin Cindy Shen, Michael A. Campitelli, Andrew J. Calzavara, Astrid Guttmann, Jeffrey C. Kwong · 2013 · Vaccine
  59. Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly
    Man-Kit Leung, Joyce H. S. You · 2016 · Vaccine
  60. Seasonality of Influenza‐Like‐Illness and Acute Cardiovascular Events Are Related Regardless of Vaccine Effectiveness
    Erin R. Kulick, Michelle Canning, Neal S. Parikh, Mitchell S.V. Elkind, Amelia K. Boehme · 2020 · Journal of the American Heart Association
  61. Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season
    Xi Li, Michael W. Deem · 2016 · Protein Engineering Design and Selection
  62. Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons
    Núria Torner, Ana Martı́nez, Luca Basile, María Ángeles Marcos, Andrés Antón, Mar Mosquera, Ricard Isanta, Carmen Cabezas, Mireia Jané, Ángela Domı́nguez et al. · 2014 · Human Vaccines & Immunotherapeutics
  63. Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty
    Martial L. Ndeffo-Mbah, Jan Medlock, Lauren W. Ancel, Alison P. Galvani, Jeffrey P. Townsend · 2013 · Vaccine
  64. The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia
    April D. Sykes, Elsie L. Gerhardt, Li Tang, Elisabeth E. Adderson · 2017 · The Journal of Pediatrics
  65. Journal of Preventive Medicine and Hygiene, Vol. 62 No. 2s1 (2021): Health Technology Assessment (HTA) dell’introduzione della vaccinazione antinfluenzale per la popolazione giovanile italiana con il vaccino Fluenz Tetra®
    Journal Of Preventive Medicine And Hygiene · 2021 · PubMed Central
  66. Strategies targeting hemagglutinin cocktail as a potential universal influenza vaccine
    Xuejie Liu, Tianyi Zhao, Liangliang Wang, Minchao Li, Caijun Sun, Yuelong Shu · 2022 · Frontiers in Microbiology
  67. The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia
    Christopher C. Blyth, Allen C. Cheng, Carolyn Finucane, Peter A. Jacoby, Paul V. Effler, David W. Smith, Heath A. Kelly, Kristine K. Macartney, Peter Richmond · 2015 · Vaccine
  68. Influenza vaccine use to protect healthy children: A debated topic
    Nicola Principi, Susanna Esposito · 2017 · Vaccine
  69. Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season
    Melia E. Bonomo, Rachel Y. Kim, Michael W. Deem · 2019 · Vaccine
  70. Estimating Vaccine-Driven Selection in Seasonal Influenza
    Frank T. Wen, Sidney M. Bell, Trevor Bedford, Sarah E. Cobey · 2018 · Viruses
  71. Effectiveness of Partial and Full Influenza Vaccination Among Children Aged <9 Years in Hong Kong, 2011–2019
    Huiying Chua, Susan Shui Seng Chiu, Eunice L.Y. Chan, Shuo Feng, Mike Yat Wah Kwan, Joshua Sung Chih Wong, Malik J. S. Peiris, Benjamin John Cowling · 2019 · The Journal of Infectious Diseases
  72. Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children
    Paul Turner, A F Abdulla, Megan E. Cole, R R Javan, Victoria Gould, Megan O’Driscoll, Jo Southern, Maria Cristina Fleischmann Alves Zambon, Elizabeth Miller, Nick J Andrews et al. · 2019 · Clinical & Experimental Immunology
  73. Variations in Seasonal Influenza Vaccine Effectiveness due to Study Characteristics: A Systematic Review and Meta-analysis of Test-Negative Design Studies
    George N. Okoli, Florentin Racovitan, Christiaan H. Righolt, Salaheddin M. Mahmud · 2020 · Open Forum Infectious Diseases
  74. The challenges of vaccine strain selection
    Amanda C. Perofsky, Martha I. Nelson · 2020 · eLife
  75. Estimates of Inactivated Influenza Vaccine Effectiveness Among Children in Senegal: Results From 2 Consecutive Cluster-Randomized Controlled Trials in 2010 and 2011
    Mbayame Ndiaye Niang, Jonathan D. Sugimoto, Aldiouma Diallo, Bou Diarra, Justin R. Ortiz, Kristen D C Lewis, Kathryn E. Lafond, M. Elizabeth Halloran, Marc‐Alain Widdowson, Kathleen Maletic Neuzil et al. · 2020 · Clinical Infectious Diseases
  76. Influenza Vaccine Effectiveness in a Low-Income, Urban Community Cohort
    Marie C. Smithgall, Celibell Y. Vargas, Carrie Reed, Lyn Finelli, Philip S. LaRussa, Elaine Larson, Lisa M. Saiman, Melissa S. Stockwell · 2015 · Clinical Infectious Diseases
  77. Real world evidence for public health decision-making on vaccination policies: perspectives from an expert roundtable
    Chiara de Waure, Barbara Christine Gärtner, Pier Luigi Lopalco, Joan Puig‐Barberà, Jonathan S. Nguyen‐Van‐Tam · 2023 · Expert Review of Vaccines
  78. Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses
    Yongqiang Zhao, Shuangshuang Guo, Jia Liu, Yating Wang, Bo Wang, Chun Peng, Enqi Du · 2025 · Frontiers in Immunology
  79. Suboptimal Effectiveness of the 2011–2012 Seasonal Influenza Vaccine in Adult Korean Populations
    Won Suk Choi, Ji Yun Noh, Ji Hyeon Baek, Yu Bin Seo, Jacob Lee, Joon Young Song, Dae Won Park, Jin Soo Lee, Hee Jin Cheong, Woo Joo Kim · 2015 · PLoS ONE
  80. Characterizing the antigenic evolution of pandemic influenza A (H1N1) pdm09 from 2009 to 2023
    Pei‐Wen Cheng, Ke Zhai, Wenjie Han, Jinfeng Zeng, Zekai Qiu, Yilin Chen, Kang Lai Tang, Jing Yan Tang, Haoyu Long, Taijiao Jiang et al. · 2024 · Journal of Medical Virology
  81. Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines
    Larry R Smith, Walter Wodal, Brian A. Crowe, Astrid Kerschbaum, Peter Bruehl, Michael G. Schwendinger, Helga Savidis-Dacho, Seán M. Sullivan, Mark Shlapobersky, Jukka Hartikka et al. · 2013 · Human Vaccines & Immunotherapeutics
  82. The coexistence or replacement of two subtypes of influenza
    Sarder Mohammed Asaduzzaman, Junling Ma, Pauline Van den Driessche · 2015 · Mathematical Biosciences
  83. Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission
    Tonia C. Carter, Scott Joseph Hebbring, Jixia Liu, Jonathan D. Mosley, Christian M. Shaffer, Lynn C. Ivacic, Sarah Kopitzke, Elisha Stefanski, Robert Strenn, Maria E. Sundaram et al. · 2017 · Journal of Medical Virology
  84. Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus
    Mallory L. Myers, John R. Gallagher, De’Marcus D. Woolfork, Regan K. Stradtmann-Carvalho, Samantha Maldonado-Puga, Kevin W. Bock, Seyhan Boyoglu-Barnum, Hubza Syeda, Adrian Creanga, Derron A. Alves et al. · 2022 · Frontiers in Immunology
  85. Costs and benefits of influenza vaccination: more evidence, same challenges
    Bruno Christian Ciancio, Giovanni Rezza · 2014 · BMC Public Health
  86. Influenza Viruses
    John J. Treanor · 2023 · Springer eBooks
  87. Effectiveness of seasonal influenza vaccine against clinically diagnosed influenza over 2 consecutive seasons in children in Guangzhou, China
    Qing He, Jianxiong Xu, Xi Chen, Jianyun Lu, Kuibiao Li, Zhaotian Li, Ming Wang, Qiongying Yang, Zhiqiang Dong, Xiangyi Liu et al. · 2013 · Human Vaccines & Immunotherapeutics
  88. Genetic and Antigenic Typing of Seasonal Influenza Virus Breakthrough Cases from a 2008-2009 Vaccine Efficacy Trial
    Serge M. Durviaux, John Jay Treanor, Jiřı́ Beran, Xavier Duval, Meral Esen, Gregory Feldman, Sharon E. Frey, Odile Launay, Geert G Leroux-Roels, Janet E. McElhaney et al. · 2013 · Clinical and Vaccine Immunology
  89. Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren)
    Cornelius Remschmidt, Thomas Harder, Ole Wichmann, Edeltraut Garbe, Thomas Ledig, Martin Terhardt, Sabine Wicker, Fred Zepp, Thomas Mertens · 2016 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  90. Harnessing Cross-Reactive CD8+ TRM Cells for Long-Standing Protection Against Influenza A Virus
    I. Uddback, J. Kohlmeier, A. Thomsen, J. Christensen · 2020 · Viral immunology
  91. Rationalizing recommendations for influenza and COVID-19 vaccines
    Jessica A. Breznik, Matthew S. Miller, Dawn M. E. Bowdish · 2025 · Vaccine
  92. Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza
    Jessie J. Goldsmith, Sarah Tavlian, Christy Vu, Annette K. Regan, Katherine B. Gibney, Patricia T. Campbell, Sheena G. Sullivan · 2025 · JAMA Network Open
  93. Analysis of R848 as an Adjuvant to Improve Inactivated Influenza Vaccine Immunogenicity in Elderly Nonhuman Primates
    Kali F. Crofts, Beth C. Holbrook, Ralph B. D’Agostino, Martha A. Alexander‐Miller · 2022 · Vaccines
  94. Serious outcomes of medically attended, laboratory‐confirmed influenza illness among school‐aged children with and without asthma, 2007‐2018
    Huong Q. McLean, Kayla E. Hanson, Allison D. Foster, Scott C. Olson, Sarah K. Kemble, Edward A. Belongia · 2020 · Influenza and Other Respiratory Viruses
  95. Role of Age in the Spread of Influenza, 2011–2019: Data From the US Influenza Vaccine Effectiveness Network
    Eric P. Griggs, Brendan L. Flannery, Ivo Foppa, Manjusha Gaglani, Kempapura Murthy, Michael L. Jackson, Lisa A. Jackson, Edward A. Belongia, Huong Q. McLean, Emily Toth Martin et al. · 2021 · American Journal of Epidemiology
  96. Use of computational and recombinant technologies for developing novel influenza vaccines
    Terianne M. Wong, Ted M. Ross · 2015 · Expert Review of Vaccines
  97. Detection of Influenza Virus Infection Using Two PCR Methods
    Richard Kent Zimmerman, Charles R. Rinaldo, Mary Patricia Nowalk, Goundappa K. Balasubramani, Mark G. Thompson, Arlene Bullotta, Michael Susick, Stephen R. Wisniewski · 2014 · Advances in Virology
  98. Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice
    Frank van Someren Gréve, Koenraad F. van der Sluijs, Anita M. Tuip‐de Boer, Marcus Josephus Schultz, Menno D. de Jong, Nicole Petra Juffermans · 2018 · Journal of Medical Virology
  99. Color-Flu Fluorescent Reporter Influenza A Viruses Allow for In Vivo Studies of Innate Immune Function in Zebrafish
    Brandy-Lee Soos, Alec Ballinger, Mykayla Weinstein, Haley Foreman, Julianna Grampone, Samuel Weafer, Connor Aylesworth, Benjamin L. King · 2024 · Viruses
  100. A computational method for identification of vaccine targets from protein regions of conserved human leukocyte antigen binding
    Lars Rønn Olsen, Christian Simon, Ulrich Johan Kudahl, Frederik Otzen Bagger, Ole Winther, Ellis L. Reinherz, Guanglan Zhang, Vladimir Brusić · 2015 · BMC Medical Genomics